"Receptors, Angiotensin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells.
| Descriptor ID |
D011945
|
| MeSH Number(s) |
D12.776.543.750.695.047 D12.776.543.750.750.130
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Angiotensin".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Angiotensin".
This graph shows the total number of publications written about "Receptors, Angiotensin" by people in this website by year, and whether "Receptors, Angiotensin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Angiotensin" by people in Profiles.
-
Escobales N, Nu?ez RE, Javadov S. Mitochondrial angiotensin receptors and cardioprotective pathways. Am J Physiol Heart Circ Physiol. 2019 06 01; 316(6):H1426-H1438.
-
De Mello WC. Local Renin Angiotensin Aldosterone Systems and Cardiovascular Diseases. Med Clin North Am. 2017 Jan; 101(1):117-127.
-
Ofili EO, Oparil S, Giles T, Pitt B, Purkayastha D, Hilkert R, Samuel R, Sowers JR. Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups. J Am Soc Hypertens. 2011 Jul-Aug; 5(4):249-58.
-
De Mello WC. Further studies on the effect of intracellular angiotensins on heart cell communication: on the role of endogenous angiotensin II. Regul Pept. 2003 Aug 15; 115(1):31-6.
-
Zaman MA, Oparil S, Calhoun DA. Drugs targeting the renin-angiotensin-aldosterone system. Nat Rev Drug Discov. 2002 Aug; 1(8):621-36.
-
Wayner MJ, Armstrong DL, Phelix CF, Wright JW, Harding JW. Angiotensin IV enhances LTP in rat dentate gyrus in vivo. Peptides. 2001 Sep; 22(9):1403-14.
-
Kram?r EA, Armstrong DL, Ikeda S, Wayner MJ, Harding JW, Wright JW. The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Res. 2001 Apr 06; 897(1-2):114-21.
-
Sun Y, Zhang J, Zhang JQ, Ramires FJ. Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats. Hypertension. 2000 May; 35(5):1078-84.
-
Keaton AK, Clark JT. Effects of angiotensin II on sexual function, blood pressure, and fluid intake are differentially affected by AT-1 receptor blockade. Physiol Behav. 1998 Jun 01; 64(3):339-46.
-
Tracy HA, Wayner MJ, Armstrong DL. Losartan improves the performance of ethanol-intoxicated rats in an eight-arm radial maze. Alcohol. 1997 Sep-Oct; 14(5):511-7.